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Aims: Tuberous sclerosis complex (TSC) is a multisystem genetic disorder
caused by a mutation in the TSC1 or TSC2 gene with a broad spectrum of
physical and psychological manifestations. The aim of the study was to ex-
amine incontinence, psychological problems, and adaptive behavior skills in
patients with TSC.
Methods: Through a worldwide TSC support group, 26 children (4‐17 years)
and 15 adults (18‐50 years) with TSC were recruited (38.1% male, mean age
16.4 years). Parents or care‐givers completed the Developmental Behavior
Checklist (DBC), the Parental Questionnaire: Enuresis/urinary Incontinence,
and the Vineland Adaptive Behavior Scales (3rd edition).
Results: A total of 60.0% of the participants had nocturnal enuresis (NE),
51.3% daytime urinary incontinence (DUI) and 52.4% fecal incontinence (FI).
65.4% of children and 50.0% of adults had a clinically relevant DBC score.
Psychological symptoms were associated with at least one subtype of incon-
tinence. The mean adaptive behavior composite (ABC) score of the patients
was 57.2 (SD= 26.1), with 38.1% in the average or below‐average range
(IQ >70), 26.2% with a mild, 11.9% with a moderate and 23.8% with a severe/
profound intellectual disability. The incontinence rate was significantly higher
in the groups with a lower ABC score.
Conclusion: A substantial proportion of patients with TSC are affected by
incontinence and psychological symptoms. Incontinence was higher in persons
with lower adaptive skills and those with at least one type of incontinence
showed a significantly higher DBC score. As incontinence and psychological
problems affect daily functioning and well‐being, assessment, and treatment
are recommended.
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1 | INTRODUCTION
Tuberous sclerosis complex (TSC) is a rare genetic dis-
order with an incidence of approximately 1:11.180‐
1:22.360 live births1 that can affect multiple organ sys-
tems. It is an autosomal dominant disorder caused by a
mutation or deletion in either the TSC1 (chromosome 9)
or TSC 2 (chromosome 16) gene, leading to an over-
stimulation of the mTOR pathway.2 Patients with a
TSC2‐gene mutation tend to be affected with a more se-
vere phenotype.3
TSC is characterized by anomalies of the skin (eg,
facial angiofibromas, fibrous cephalic plaques, ungual
fibromas, hypomelanotic macules), kidney (angiomyoli-
pomas, renal cell carcinomas, cysts), heart (arrhythmias,
rhabdomyomas), brain (subependymal giant cell astro-
cytomas, subependymal nodules and cortical dysplasias,
seizures, intellectual disability/developmental delay,
psychiatric illness), and lungs (lymphangioleiomyoma-
tosis, multifocal micronodular pneumonocyte hyperpla-
sia). Tumors of the central nervous system are the leading
cause of morbidity and mortality, followed by renal
diseases.2
Besides neurological, skin, and renal manifestations
TSC‐associated neuropsychiatric disorders (TAND) can
occur in patients. This term describes a range of neu-
ropsychiatric manifestations including behavioral, psy-
chiatric, intellectual, academic, and psychosocial
problems.4 TSC patients have an increased risk of a co-
morbid autism spectrum disorder, attention deficit hy-
peractivity disorder, disruptive behavior as well as high
levels of anxiety and depressive disorders.2 The estimated
prevalence of intellectual disability in persons affected by
TSC ranges from 50% to 65%.5 The IQ‐distribution is bi-
modal with one peak in the range of severe ID and a
second peak with an almost normal IQ‐distribution.
Approximately a third of all children with TSC have
academic difficulties.5 Another measure for intellectual
ability is the adaptive behavior composite (ABC) standard
score. It has an IQ scale (mean = 100, SD= 15) and cor-
relates significantly to the IQ of the individual. The ABC
score includes scores of different adaptive behavior
domains.
Functional incontinence includes daytime urinary
incontinence (DUI), nocturnal enuresis (NE), and fecal
incontinence (FI). NE and DUI are diagnosed according
to the International Children's Continence Society (ICCS)
from the age of 5 years onwards (with a wetting fre-
quency of at least 1×/month) after exclusion of organic
causes.6 Encopresis is diagnosed according to the Diag-
nostic and Statistical Manual of Mental Disorders – Fifth
Edition (DSM‐5) from the age of 4 years onwards
(occurring at least 1×/month) after exclusion of organic
causes. Non‐retentive FI can be differentiated from
functional constipation according to ROME‐IV criteria.7
In typically developing children, the prevalence is
approximately 5% to 10% for NE, 6% for DUI, and 1% to
8% for FI, with decreasing rates into adolescence and
adulthood.8 In individuals with intellectual disability
(ID), incontinence is more prevalent (30%‐39% in 7‐year‐
olds, 19%‐20% in 20‐year‐olds) and is associated with the
degree of intellectual disability (ID).9
In children with TSC estimated 80% were affected by
renal disease, for example, angiomyolipoma of the kidney
or renal cystic disease.2
In the study by Backes et al of nonorganic (func-
tional) incontinence, 2 of 16 boys with TSC had NE and
only one FI. Associated symptoms were not assessed and
severely affected children with TSC were excluded.10
Due to the lack of previous studies, the aim of this
study was to analyze the prevalence of subtypes of non-
organic (functional) incontinence (NE, DUI, FI) in in-
dividuals with TSC. Associations between incontinence,
psychological symptoms, and adaptive abilities were ex-
amined. It was hypothesized that individuals with TSC
show symptoms of incontinence and that the rate of in-
continence increases with the degree of impairment of
adaptive functions, as well as with psychological
symptoms.
2 | MATERIALS AND METHODS
The study was announced on the homepage of the
Tuberous Sclerosis Alliance Support Group (US) with
study information and a link to a questionnaire. Ques-
tionnaires were provided in English and could be re-
quested online by interested families. The packages were
sent by mail to the families. After parents or caregivers
gave their informed consent, they were asked to complete
the questionnaires and send them back anonymously.
Altogether, 111 questionnaires were sent over a time of
14 months (February 2017 until March 2018). The package
included an information letter for parents or caregivers
concerning the study and three questionnaires on psy-
chological symptoms, incontinence, and adaptive skills.
The study was approved by the local ethics committee.
Psychological symptoms were assessed using the De-
velopmental Behavior Checklist (DBC).11,12 The DBC is
composed of five subscales (“Disruptive/Antisocial”,
“Self‐Absorbed”, “Communication Disturbance”, “Anxi-
ety” and “Social Relating”) that add up to the total be-
havior problem score (TBPS). Caregivers or parents filled
out either the adult version (DBC‐A) for adults or the
version of the DBC for children or adolescents (DBC‐P).
The version for adults (DBC‐A) has an additional scale
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for “Depression”. Clinically relevant scores are defined as
a TBPS >46 in the DBC‐P and as a TBPS >51 in the DBC‐
A, respectively and represent psychological symptoms of
the individual which cause distress and impairment and
correlate with potential psychiatric diagnoses.11,12 In
addition, both versions of the DBC total scores can be
expressed in percentiles according to norms for children
and adults with mild, moderate, and severe intellectual
disability.11,12 The DBCt has a significant concurrent
validity with questionnaires and expert rating (DBC‐P:
r = 0.72‐0.86; DBC‐A: r = 0.52‐0.63) and high reliability
(DBC‐P: r = 0.80‐0.83; DBC‐A: r = 0.69‐0.72).11,12
The “Parental Questionnaire: Enuresis/Urinary
Incontinence”13 and the “Encopresis Questionnaire –
Screening Version”14 assesses incontinence and asso-
ciated symptoms, as well as voiding and stool behavior.
The “Parental Questionnaire: Enuresis/Urinary Incon-
tinence” consists of 41 items and has been validated with
satisfying psychometric properties.15 As defined by the
ICCS, NE and DUI were diagnosed in persons older than
5 years when wetting occurs at least once per month.6
According to DMS‐5, FI was diagnosed from the age of 4
years when soiling occurs at least once per month.16
Adaptive behavior was measured with the Vineland
Adaptive Behavior Scales, Third Edition (Vineland‐III).
There are three different comprehensive administration
forms. We used the Parent/Caregiver Form (domain‐
level) in our study. It is the third revision of the first
standardized measure of adaptive behavior.17 The
Vineland‐III assesses three core adaptive behavior
domains: daily living skills, or the ability to take care of
one´s daily needs, communication (receptive, expressive,
and written communication), and socialization. For
children, 9 years and younger, the gross and fine motor
skills can be assessed within the motor skills domain. In
addition, the maladaptive behavior domain was added.17
The Vineland‐III can be administered for individuals
from birth through age 90 years. An overall adaptive
behavior composite (ABC) standard score can be mea-
sured, as well as standard scores for each of the adaptive
behavior domains.17 The Vineland‐III questionnaire
measures the adaptive behavior of an individual in a valid
and reliable way and reports outcomes as the ABC‐score.
The ABC score has an IQ scale (mean = 100, SD = 15)
and correlates significantly to the IQ of the individual.
The Vineland scales evaluate whether or not a person
could meet diagnostic criteria for intellectual disability,
which was demonstrated in validation studies.17 For
further analyses, the ABC scores were subdivided in
analogy to IQ levels.
Statistical analyses were performed using IBM SPSS
Statistics 23 (IBM, Armonk, NY). Descriptive statistics,
nonparametric tests (Chi Square tests, Fisher's Exact
tests) for categorical data, and analysis of variance for
parametric data (post hoc tests) were performed. At a
P‐value < .05, results were considered significant.
3 | RESULTS
Out of 111 families, 46 returned the packages (41.4%).
Three participants were excluded due to an age of less
than 4 years. One additional data set had to be excluded
since the questionnaires were not complete. Thus, in
total, we included 42 full data sets for the final analysis
(37.8%). Three incontinence questionnaires had missing
data and were also excluded from data analysis regarding
incontinence analysis.
3.1 | Descriptive data
Descriptive data are shown in Table 1. The sample was
divided into three age groups (children: 4‐12 years,
n = 21; teens: 13‐17 years, n = 5; adults ≥18 years,
n = 16). The mean age of the sample was 16.4 years
(range 4‐50 years). The sample consisted of 16 male and
26 female participants. Medical conditions concerning
kidneys, ureters, bladder, and urethra were reported in
66.7% of cases. 90.5% of patients had current seizures or a
history of seizures. 50% (n = 8) of the participants had a
DBC‐A score and in 65.4% (n = 17) a DBC‐P score in the
clinical range. The mean adaptive behavior composite
(ABC) standard score for the whole sample group
(n = 42) was 57.2 (SD = 26.1; range 20‐119).
3.2 | Subtypes of incontinence
A total of 82.1% (n = 32) of 39 persons with TSC were
affected by at least one subtype of incontinence. Data for
(NE) was available for 40 persons, 24 of them were af-
fected (60%). The rates for (DUI) were 51.3% (n = 20 of
39) and 52.4% for FI. Constipation was reported in 14
(35.0%) of 40 individuals.
3.3 | Incontinence, behavior and
adaptive abilities over age groups
Data in different age groups are presented in Table 2. Rates
of incontinence subtypes were high in all age groups, ran-
ging from 90.5% in children to 69.2% in adults. Rates of NE,
DUI, and FI were lower in the adult group, but the differ-
ence did not reach statistical significance. Also, constipation
rates were similar between the age groups.
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In addition, the rate of clinically relevant behavioral
problems (DBC) was high (58.5% of the entire group),
affecting 70.0% of children and 50.0% of adults (Table 2).
There was no significant difference between age groups.
3.4 | Incontinence and DBC scores
Incontinence rates in individuals with clinically relevant
psychological symptoms vs those with subclinical symp-
toms (according to DBC scores) are presented in Table 3.
Individuals with clinically relevant DBC scores show
significantly higher rates of incontinence overall, NE and
DUI, but not FI, than individuals with a subclinical DBC
score.
3.5 | Incontinence and adaptive
behavior categories
Table 4 shows the rates of NE, DUI, and FI over the three
groups of the ABC score of the entire sample. The sample
was divided into three groups according to their ABC
scores in analogy to levels of intelligence: group 1
(ABC> 70) included individuals with an average ABC
score (>85) (n = 4) and those with a subaverage score
(85‐70) (n = 12); group 2 (ABC 50‐70) consisted of in-
dividuals with mild impairment (50‐69) (n = 11); and
group 3 (ABC <50) included those with moderate (35‐49)
(n = 5) and severe (<35) (n = 10) impairment.
The rates of at least one subtype of incontinence in-
creased from 66.7% in the group with an ABC score >70
to 90.9% in the group with an ABC score 50 to 70 to 92.3%
in the group with an ABC score <50, respectively. There
was a significant difference in‐between the two groups
(ABC >70; ABC <50) regarding the prevalence of DUI
(ABC >70 25.0%; ABC <50 83.3%; P= .009) as well as the
prevalence of NE (ABC >70 35.7%; ABC <50 80.0%;
P= .050). The rate of FI differed significantly (P= .020)
between those with an ABC >70 (25.0%) and those with
an ABC 50 to 70 (72.7%).
4 | DISCUSSION
This is the first study that analyzed the associations be-
tween incontinence, behavior, and adaptive skills in in-
dividuals with TSC. Our data confirmed and extend the
results by Backes et al10 who described a much smaller
sample. To our knowledge, this is the second study to
examine incontinence.
In our sample 62.0% (n= 26) had an estimated level of
adaptive skills lower than 70, that is, corresponding with
ID. Those results are consistent with other studies show-
ing a prevalence between 50% to 65% of intellectual dis-
ability in people with TSC.5 With a decreasing ABC score,
the rates of incontinence increased in our group of parti-
cipants. Hence, our results confirm our assumption that
the prevalence of functional incontinence increases with
the growing impairment of adaptive functions.9 Except for
FI, which showed the highest prevalence in the group of
an ABC score 50 to 70, the other two subtypes presented
the largest rate in the group of individuals with an ABC
score of less than 70. Individuals with an average ABC
score were underrepresented, probably due to selection
effects in the recruitment process through an international
support group. Therefore, the typical bimodal distribution
of intelligence represented by adaptive levels was not
apparent in this sample.5
TABLE 1 Descriptive data, somatic conditions, subgroups of
incontinence, and ABC score of the total sample
Total (N= 42)
Mean age in years (SD) 16.4 (10.8)
Children: 4‐12 y % (n) 50.0 (21)
Teens: 13‐17 y % (n) 11.9 (5)
Adults ≥18 y % (n) 38.1 (16)
Males % (n) 38.1 (16)
Females % (n) 61.9 (26)
Kidneys, ureters, bladder, and urethra
affected% (n)
68.3 (28/41)
Seizures or history of seizures% (n) 92.7 (38/41)
Clinical DBCa,b‐P % (n) 65.4 (17/26)
Clinical DBCa,b‐A % (n) 50.0 (8/16)
Incontinence overallc % (n) 82.1 (32/39)
Nocturnal enuresis (NE) 60.0 (24/40)
Daytime urinary incontinence (DUI) 51.3 (20/39)
Fecal incontinence (FI) 52.4 (22)
Constipation % (n) 33.3 (14/40)
Mean adaptive behavior (ABC) composite
score (SD)
57.2 (26.1)
Domain communication, mean (SD) 54.7 (26.7)
Daily living skills, mean (SD) 55.0 (30.8)
Socialization (SD) 60.7 (25.8)
Motor skills (SD; n) 73.3 (18.0; 12)
aDBC=Developmental Behavior Checklist; TBPS = total behavior problem
score.
bClinical DBC is defined as a TBPS >46 in DBC‐P or TBPS >51 in the
DBC‐A.
cAt least one subtype of incontinence.
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The overall rate of incontinence in individuals with
TSC was 82.1% in our study, which is a higher rate than
in persons with severe intellectual disability9 but lower
compared to individuals with other syndromes such as
Mowat‐Wilson syndrome and Angelman syndrome.18,19
The rates of all three types of incontinence were com-
parable. The prevalence was much higher than in the
study Backes et al, which had excluded all severely
affected participants with TSC.
Even though the rates decreased over age, 69.2%
continued to show symptoms of at least one type of in-
continence as an adult. This could be due to the fact that,
persons with a low adaptive skill have not received ade-
quate treatment for incontinence and that especially
adults might have not been examined for symptoms of
incontinence.20 In addition, 68.3% of patients were af-
fected by upper and lower urinary tract disorders, which
is much higher than in other syndromes. For example, in
TABLE 2 Incontinence, DBC score, and adaptive behavior score over age groups
Total N= 42
Children
(4‐12 y) N= 21
Teens
(13‐17 y) N= 5
Adult
(>18 y) N= 16 Significancec
Mean age in years (SD) 16.4 (10.8) 8.5 (2.8) 15.4 (1.7) 27.0 (10.1)
Incontinence overalla, % (n) 82.1 (32/39) 90.5 (19) 80.0 (4) 69.2 (9/13) n.s.
Nocturnal enuresis, % (n) 60.0 (24/40) 65.0 (13/20) 80.0 (4) 46.7 (7/15) n.s.
Daytime urinary Incontinence,
% (n)
51.3 (20/39) 52.4 (11) 60.0 (3) 46.2 (6/13) n.s.
Fecal incontinence % (n) 52.4 (22) 57.1 (12) 80.0 (4) 37.5 (6) n.s.
Clinical DBC total score % (n) 58.5 (24/41) 70.0 (14/20) 40.0 (2) 50.0 (8) n.s.
Mean ABCb score (SD) 57.2 (26.1) 62.9 (17.8) 38.6 (27.5) 55.6 (32.7) n.s.
Abbreviations: ABC, adaptive behavior composite; DBC, Developmental Behavior Checklist; na, not available; n.s., not significant; SD, standard deviation.
aAt least one subtype of incontinence.
bAdaptive behavior composite standard score.
cFisher's exact test for non‐parametric data and ANOVAs for parametric data (Welch test in case of variance inhomogeneity).
TABLE 3 Distribution of incontinence subtypes between individuals with a clinical vs a subclinical Developmental Behavior Checklist
(DBC) score
Clinical DBC scoreb (n = 24) Subclinical DBC score (n = 17) Significance
Incontinence overall % (n) 95.5 (21/22) 62.5 (10/16) .028*a
Nocturnal enuresis (NE) % (n) 77.3 (17/22) 41.2 (7) .022*
Daytime urinary incontinence (DUI) % (n) 63.6 (14/22) 31.3 (5/16) .049*
Fecal incontinence (FI) % (n) 58.3 (14) 41.2 (7) n.s.
aFisher's exact tests.
bdefined as a Total score >46 in the DBC‐P and >51 in the DBC‐A.
TABLE 4 Rates of nocturnal enuresis, daytime urinary incontinence, and fecal incontinence over three groups of the ABC score:
average and subaverage IQ, mild and moderate intellectual disability.
Total N= 42
ABC> 70 N= 16 ABC 50‐70 N= 11, ABC< 50 N= 15
P1 2 3
Incontinence overalla % (n) 82.1 (32/39) 66.7 (10/15) 90.9 (10) 92.3 (12/13) n.s.
Nocturnal enuresis % (n) 60.0 (24/40) 35.7 (5/14) 63.6 (7) 80.0 (12) .050* (3 > 1)
Daytime urinary incontinence % (n) 51.3 (20/39) 25.0 (4) 54.5 (6) 83.3 (10/12) .009** (3 > 1)
Fecal incontinence % (n) 52.4 (22) 25.0 (4) 72.7 (8) 66.7 (10) .020* (2 > 1)
aAt least one subtype of incontinence.
*P <.05.
**P <.01.
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one large study on Williams syndrome, the rate was
only 8.1%.21
Compared to our findings, the rates of seizures or a
history of seizures of 80% to 90% in previous studies22 did
not differ from our sample (92.7%). Due to the lack of
information, the associations between the type, fre-
quency, severity, and onset of seizures and incontinence
could not be analyzed. Also, the number, size, and loca-
tion of intracerebral fibromas, subependymal nodes,
subependymal giant cell astrocytomas were not reported.
In other syndromes such as Angelman syndrome, sei-
zures and incontinence are clearly associated.19
More than 50% of the participants with a clinically
relevant DBC score had significantly higher rates of in-
continence, NE, and DUI than those without clinically
relevant psychological symptoms. The typical behavioral
phenotype of TSC includes attention‐deficit/hyperactivity
disorder, autism spectrum disorders, anxiety, and de-
pressive disorders, all of which are associated with in-
continence in typically developing children.23 Overall,
more than 90% of children and adults with TSC are af-
fected by one or more TSC‐associated neuropsychiatric
disorders (TAND).4,24 Despite this high rate, only 20% of
TSC patients receive a diagnosis and treatment of their
neuropsychiatric disorder, which is associated with
higher parental stress.4,24,25
4.1 | Clinical implications
As treatment of functional, nonorganic is effective in
persons with special needs and lower adaptive skills,20
thorough assessment and specific treatment options
should be offered to affected individuals with TSC.
4.2 | Strengths and limitations
This is the first description of incontinence in a group of
people with TSC with different levels of adaptive skills.
Also, validated instruments were used and the diagnoses
of incontinence were established according to DSM‐5 and
ICCS criteria.
Limitations are the small sample size in some of the
groups and the cross‐sectional design that prohibits the
analysis of causal associations. In addition, the study was
based on questionnaire data and not on clinical ex-
amination. Due to the participation rate of 41.4% the
sample is possibly not representative and selection biases
cannot be excluded. We cannot rule out that possibly
families more affected by children with incontinence
mainly responded. Therefore, a potential higher pre-
valence of incontinence in our study could be the result.
5 | CONCLUSION
The present study shows that a high number of individuals
with TSC are affected by incontinence into and throughout
adulthood. Although the rates decreased over age, the ma-
jority still showed symptoms of incontinence after the age of
18 years. Especially adults with a low adaptive skill score
showed a high prevalence of incontinence and clinically re-
levant behavioral problems. Therefore, incontinence and all
comorbid symptoms and disorders should be evaluated in all
age groups. Clinicians should offer treatment of incontinence
regardless of the cognitive development of their patients.
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